��������

Kathy Boon is an experienced regulatory affairs and project management professional with a strong background in the pharmaceutical and biotechnology sectors. Currently serving as Manager of Regulatory Affairs at Curium Pharma since October 2016, Kathy previously held positions including Interim Regulatory Affairs Assistant at Mallinckrodt Pharmaceuticals and Clinical Registry Project Manager at The Janssen Pharmaceutical Companies, focusing on EudraCT submissions and European Medicines Agency regulations. Kathy's extensive career also encompasses roles as Project Leader for Product Development at MRC-Holland, Program Manager at excerpta Medica BV-Adelphi Group, and Associate Director of R&D at Qiagen Sciences, demonstrating expertise in project management, scientific research, and regulatory compliance. Holding a PhD in Biochemistry from Leiden University and a Master's degree in Chemistry from Vrije Universiteit Amsterdam, Kathy has made significant contributions to cancer genomics and epigenetics research throughout their career.